广发创新医疗两年持有混合C(010732)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-37,386,315.21 |
-56,311,338.78 |
-94,024,385.96 |
-82,279,566.40 |
利息合计 |
179,646.42 |
79,268.93 |
204,627.42 |
84,421.88 |
其中:存款利息收入 |
179,646.42 |
79,268.93 |
204,627.42 |
84,421.88 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-48,295,487.30 |
-45,067,997.20 |
-163,076,008.51 |
-115,577,014.73 |
其中:股票投资收益 |
-51,517,982.07 |
-47,335,065.02 |
-167,132,571.32 |
-118,468,116.57 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
31,020.63 |
31,020.63 |
2,814.04 |
2,814.04 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
3,191,474.14 |
2,236,047.19 |
4,053,748.77 |
2,888,287.80 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
10,729,525.67 |
-11,322,610.51 |
68,846,995.13 |
33,213,026.45 |
其他收入 |
- |
- |
- |
- |
费用 |
5,501,683.80 |
2,859,153.54 |
8,951,186.90 |
5,466,058.00 |
管理人报酬 |
4,297,303.88 |
2,235,875.86 |
7,098,344.38 |
4,367,001.40 |
基金托管费 |
716,217.26 |
372,645.97 |
1,183,057.41 |
727,833.61 |
销售服务费 |
304,822.49 |
159,253.35 |
470,448.32 |
270,442.38 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
183,340.05 |
91,378.24 |
199,336.79 |
100,780.61 |
利润总额 |
-42,887,999.01 |
-59,170,492.32 |
-102,975,572.86 |
-87,745,624.40 |